March Biosciences is developing advanced cell therapies, targeting complex diseases like cancer and genetic disorders through precision medicine approaches. Their lead asset, MB-105, selectively targets CD5, a widely expressed antigen both in normal and malignant T-cells.

Groq provide fast AI inference in the cloud and in on-prem AI compute centers. Their core product is the GroqChip, a unique tensor streaming processor (TSP) architecture specifically built to accelerate AI workloads, such as deep learning, natural language processing, and computer vision

PathPresenter is an enterprise workflow platform powered by Microsoft Azure Cloud, offering exceptional imaging performance and data integrity, with the flexibility to function in a hybrid data environment.

Komo Biosciences enables accelerated development and manufacturing of therapeutics by translating the utility of high-efficiency integrases to high-efficiency therapeutic development and manufacturing processes.

Latus Bio is developing curative medicines for neurological diseases, enabled by unprecedented AAV capsids that unlock new possibilities for patient care.

Rubedo discovers and develops medicines to keep you biologically young by targeting the pathologic cells that drive aging.

Aether uses its state of the art platform to rapidly engineer enzymes, enabling our customers to manufacture complex and novel products at fractional cost.

Developing the next generation of induced-proximity medicines

Wearable neurotechnology that augments sleep, attention, and ultimately the human experience.

Tiny Health is the first gut health test for moms and babies 0-3 years. They detect gut imbalances and course correct early on.

Ozlo is on a mission to clinically enhance rest without pharmaceutical intervention – and the associated side effects – to improve both wakefulness and the quality of mental and physical well-being.